sollazon 100 mg tabletes
egis pharmaceuticals plc, hungary - cilostazols - tablete - 100 mg
nicorette coolmint 1 mg/devā aerosols izsmidzināšanai mutes dobumā, šķīdums
mcneil ab, sweden - nikotīns - aerosols izsmidzināšanai mutes dobumā, šķīdums - 1 mg/devā
sollazon 50 mg tabletes
egis pharmaceuticals plc, hungary - cilostazols - tablete - 50 mg
phezam 400 mg/25 mg cietās kapsulas
teva b.v., netherlands - piracetamum, cinnarizinum - kapsula, cietā - 400 mg/25 mg
flexbumin 200 g/l šķīdums infūzijām
baxalta innovations gmbh, austria - albumīns, cilvēka - Šķīdums infūzijām - 200 g/l
ketorolac baxter 30 mg/ml šķīdums injekcijām
baxter holding b.v., netherlands - ketorolacum trometamolum - Šķīdums injekcijām - 30 mg/ml
ketorolac baxter 10 mg/ml šķīdums injekcijām
baxter holding b.v., netherlands - ketorolaka trometamols - Šķīdums injekcijām - 10 mg/ml
ketanov 30 mg/ml šķīdums injekcijām
sun pharmaceutical industries europe b.v., netherlands - ketorolacum trometamolum - Šķīdums injekcijām - 30 mg/ml
ketanov 10 mg mutē disperģējamās tabletes
ranbaxy uk ltd., united kingdom - ketorolaka trometamols - mutē disperģējamās tabletes - 10 mg
carmustine medac (previously carmustine obvius)
medac gesellschaft für klinische spezialpräparate mbh - karmustīns - hodgkin disease; lymphoma, non-hodgkin - antineoplastiski līdzekļi - carmustine is indicated n adults in the following malignant neoplasms as a single agent or in combination with other antineoplastic agents and/or other therapeutic measures (radiotherapy, surgery): , brain tumours (glioblastoma, brain-stem gliomas, medulloblastoma, astrocytoma and ependymoma), brain metastases, secondary therapy in non-hodgkin’s lymphoma and hodgkin’s disease, as conditioning treatment prior to autologous haematopoietic progenitor cell transplantation (hpct) in malignant haematological diseases (hodgkin’s disease / non-hodgkin’s lymphoma).